From lab to market: Monetizing R&D
It's one thing to invent something cool within controlled laboratory environments. It's entirely another to scale that new baby for sale.
The tension between innovation and commercialization is something we regularly wrestle with at Abstrax. Every morning, we don lab coats and ask the same question: 'How do you make money from research done in a lab?'
Balance innovation with commercial reality
Discovery for its own sake isn't enough. Many R&D-heavy companies discover that brilliant ideas can languish for years if they don't have a system for bringing them to market.
We decided early on to build that bridge proactively. This meant investing heavily not just in research, but in the systems and machinery that connect lab work to real-world products. Our scientists don't concoct in ivory towers, they work hand-in-hand with product developers to ensure (most) experiments align with market needs.
This pragmatic approach focuses our curiosity. We poured resources into advanced analytical technology. Among other exquisite toys, we operate an ultra-sensitive aroma analysis platform nicknamed OMNI. With it, we can break down a complex flavor into hundreds of molecular components and pinpoint the ones that matter. By capturing a '3D metabolite fingerprint' of a material (cannabis flower, hop varietals, etc.), we get a complete map of that sample's aroma chemistry.
Why go to these extremes? Because understanding a flavor at that granular level is the key to replicating it, enhancing it, and ultimately monetizing it. We can identify over 500 distinct compounds in a single hop strain. That level of resolution lets us see opportunities others might miss, like the trace molecules that round out pineapple, or a sulfur compound responsible for 'skunky' notes.
From breakthrough to beer glass
To illustrate how lab research turns into revenue, take our recent work with Citra, one of the most celebrated hops in craft brewing. Citra's appeal lies in its remarkably juicy, complex flavor—think grapefruit, lime, peach, and passionfruit steamrolled into one. This tropical medley makes a Citra-hopped beer delicious. But here's the rub: Achieving that same flavor consistently at scale is hard. Hops are agricultural products, subject to the whims of weather and yearly variation. The Citra you get this year might not taste exactly like last year's crop.
This is where our lab-to-market philosophy shines. Using OMNI, we profiled Citra's chemical makeup in exquisite detail. Armed with that 'blueprint,' we developed an Omni Hop Profile extract that mirrors Citra's flavor profile with uncanny accuracy. For brewers, this is a game-changer. Instead of being at the mercy of Mother Nature, they can rely on our Citra extract to deliver the exact same flavor in every batch, forever. And because it's made from botanically derived ingredients, it stays true to the clean-label standards brewers abide by. We even worked with veteran brewmasters on pilot brews to fine-tune the extract's performance in different beer styles. By the time our Citra profile hit the market, it was brewer-tested and production-ready.
Our Citra victory highlights our core principle of reasonable innovation. We didn't stop at discovering what makes that hop special, we pushed to make it a tangible solution to a real problem. That is the essence of monetizing R&D: moving from 'Eureka!' to a viable SKU.
No fluff, only real solutions
In avant-garde industries like cannabis and craft beer, it's easy to get caught up in hype and bold claims. We prefer a different tack: Let the results speak. If we say our new formulation improves a beer's shelf-life or an extract boosts an IPA's aroma, we've got the data to back it up. Grounding innovation in evidence keeps us credible and ensures we stay focused on real market value.
We also recognize that not every experiment will pan out, and that's okay. Part of our system is knowing never to become 100% pot committed. We'll test 10 ideas, then swiftly double down on the one or two that show commercial promise. By failing fast and smart, we conserve resources for the innovations that count.
The new R&D playbook
Our journey from lab to market hasn't been quick or easy. It took patience and a willingness to invest up front. But that patience is paying off. Today, Abstrax's approach is turning niche scientific insights into mainstream products. What others consider to be a cost center is our engine for growth.
When scientists and strategists work in sync, every discovery is viewed through the lens of real-world impact. The healthy tension between invention and commercialization keeps us sharp. As it turns out, the lab and the market are pretty good at balancing each other.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Chicago Sky Star Makes Demand After Loss on Sunday
Chicago Sky Star Makes Demand After Loss on Sunday originally appeared on Athlon Sports. The Chicago Sky lost to the Atlanta Dream on Sunday, falling to 3-10 on the WNBA season. While it ultimately goes down as another tally in a growing loss column, there were some positive developments for Chicago. Advertisement One encouraging sign for the Sky was how reserve center Elizabeth Williams performed. The 2017 All-Star tallied 16 points and five rebounds off the bench. While this marked a season-high in scoring for Williams, she had bigger things on her mind after the game. As the secretary of the WNBA Player's Association, Williams demanded player salaries begin reflecting the league's growth in recent years. Chicago Sky center Elizabeth Williams (1).Chris Jones-Imagn Images As reported and transcribed by Sky reporter Karli Bell, Williams issued a clear message: "On behalf on my teammates and every member of our union, I want to be clear that we remain committed to negotiating the next CBA with the league and the teams in good faith and privately, but we do want to set the record straight not for the headlines but for the fans who support us and deserve transparency about what's at stake." Advertisement She added, "This is a defining moment for the WNBA. As the league grows, it's time for a CBA that reflects our true value... We deserve a fair share, and we're demanding salaries that reflect our true value." Last month, Ben Pickman of The Athletic provided some insight into the ongoing CBA negotiations. "Players are coming to the negotiating table with several priorities, including increased salaries, a softened salary cap and more access to family planning services," he reported. "Retirement benefits that provide long-term security for players and their families are also among key priorities, and standardizing team work environments, including facility and travel accommodations as well as support staff minimums, are on the list too." Advertisement Related: Chicago Sky Announce Angel Reese Injury News After Ninth Loss This story was originally reported by Athlon Sports on Jun 22, 2025, where it first appeared.
Yahoo
31 minutes ago
- Yahoo
Texas governor vetoes bill that would ban all THC products
AUSTIN, Texas (AP) — Texas Gov. Greg Abbott vetoed a bill Sunday to ban all THC consumables, allowing the booming market flush with THC-infused vapes, gummies and other products to continue to be sold across the state. Abbott, a Republican, waited until the final moment to veto the bill in what would have been one of the most restrictive THC bans in the country and a significant blow to the state's billion-dollar industry. The law would have made it a misdemeanor to own, manufacture or sell consumable THC, or tetrahydrocannabinol, products and was the latest push by states to regulate THC after a 2018 federal law allowed states to regulate hemp, a similar plant to marijuana that can be synthetically processed to produce THC, the compound giving marijuana its psychoactive properties. Loopholes in existing law have allowed many THC-infused goods to enter the market across the country, including states with strict marijuana laws. Texas has some of the strictest marijuana laws in the country, prohibiting all recreational use and providing a limited medical marijuana program. The consumables market has allowed residents to legally access goods giving a similar high to marijuana. Republican lawmakers have criticized the products as dangerous due to a lack of federal oversight in how the goods are manufactured. Texas' ban is one of the more far-reaching among states that have taken similar steps. Several states, including California, have imposed age limits and restrictions on the potency of THC products. Critics of the Texas bill say it allows people who cannot access marijuana through the state's medical marijuana program to acquire goods that can provide a similar relief. Many retailers across the state also pointed to the thousands of jobs and millions in revenue the industry brings each year. Last year, Florida Republican Gov. Ron DeSantis vetoed a bill that would have put age restrictions on THC consumables, claiming it would hurt small businesses. ___ Lathan is a corps member for the Associated Press/Report for America Statehouse News Initiative. Report for America is a nonprofit national service program that places journalists in local newsrooms to report on undercovered issues. Nadia Lathan, The Associated Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
31 minutes ago
- Associated Press
Texas governor vetoes bill that would ban all THC products
AUSTIN, Texas (AP) — Texas Gov. Greg Abbott vetoed a bill Sunday to ban all THC consumables, allowing the booming market flush with THC-infused vapes, gummies and other products to continue to be sold across the state. Abbott, a Republican, waited until the final moment to veto the bill in what would have been one of the most restrictive THC bans in the country and a significant blow to the state's billion-dollar industry. The law would have made it a misdemeanor to own, manufacture or sell consumable THC, or tetrahydrocannabinol, products and was the latest push by states to regulate THC after a 2018 federal law allowed states to regulate hemp, a similar plant to marijuana that can be synthetically processed to produce THC, the compound giving marijuana its psychoactive properties. Loopholes in existing law have allowed many THC-infused goods to enter the market across the country, including states with strict marijuana laws. Texas has some of the strictest marijuana laws in the country, prohibiting all recreational use and providing a limited medical marijuana program. The consumables market has allowed residents to legally access goods giving a similar high to marijuana. Republican lawmakers have criticized the products as dangerous due to a lack of federal oversight in how the goods are manufactured. Texas' ban is one of the more far-reaching among states that have taken similar steps. Several states, including California, have imposed age limits and restrictions on the potency of THC products. Critics of the Texas bill say it allows people who cannot access marijuana through the state's medical marijuana program to acquire goods that can provide a similar relief. Many retailers across the state also pointed to the thousands of jobs and millions in revenue the industry brings each year. Last year, Florida Republican Gov. Ron DeSantis vetoed a bill that would have put age restrictions on THC consumables, claiming it would hurt small businesses. ___ Lathan is a corps member for the Associated Press/Report for America Statehouse News Initiative. Report for America is a nonprofit national service program that places journalists in local newsrooms to report on undercovered issues.
